Since serum MMP-2 and TIMP-1 decreased significantly and serum PIIINP did not changed significantly in the entire cohort, one could assumed that PD treatment in CHF patients has a more profound effect on collagen degradation than on collagen synthesis rate. The gene discussed is MMP2; the disease is congestive heart failure.